Denmark· DK-28101709294
Zoladex
A goserelin product containing goserelinacetat, registered in Denmark by Astrazeneca A/S. The same ATC class is registered in 12 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Goserelin is registered in 12 of 19 countries.
Countries holding a registration under ATC L02AE03 (goserelin), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 8 of them publish a price we can compare per daily dose
Goserelin · ATC L02AE03
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
Price per daily dose
What a daily dose of goserelin costs, country by country.
Normalised to the WHO defined daily dose (0.129 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Goserelin · price per daily dose (0.129 mg)
USD · FX 28 Sept 2026
- CH Switzerland$5.39
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- GOSERELINACETAT
- Manufacturer
- Astrazeneca A/S
- Country
- Denmark (DK)
- ATC code
- L02AE03
- ATC class
- Goserelin
- Defined daily dose
- 0.129 mg, Implantat
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28101709294
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
461 interactions on record for goserelin.
Graded by severity as the source publishes them — 71 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Goserelin · interactions on record
461 records
- 71 severe
- 250 moderate
- 3 minor
- 137 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- QuinidineC01BA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under L02AE03
Goserelin, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4b21c066-7997-4ee5-a4ae-c67b219cdd58 GET /v1/drugs/4b21c066-7997-4ee5-a4ae-c67b219cdd58?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "implantat, fyldt injektionssprøjte",
"source": "dkma",
"strength": "10,8 mg",
"auth_role": "DKMA",
"dk_drugid": "28101709294",
"substance": "GOSERELINACETAT",
"auth_procedure": "National",
"in_medicinpriser": true,
"registration_date_serial": "35046"
}See everything about goserelin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.